Connecting you with your industry every day
GSK's Australian Country Leader Andrew Thomas tells how being open to 'taking a shot' created a global high-flying career and offers tips on how pharma professionals can get ahead, in a new book called Work Fame
Talent movements across industry include a new role after redundancy, a move to a new country and leaving a company after 18 years
Pioneering contributions to help eliminate malaria has earned this scientist Novo's coveted Young Women in Science Award plus $50K to continue her research
This company has two generics ready to launch but has agreed to hold off ahead of a Full Federal Court hearing scheduled for next year in which a franchise worth $170M will be challenged
It's been a tough few years in pharma but this Australian recruitment expert warns that staying put in your current role just for job security is riskier than you think
This company was found to have breached the Code of Practice after it voluntarily reported improperly disclosed grants worth more than $1.3M made more than four years ago
This agency alongside its pharma client have been awarded Bronze in Health Marketing, a category that finally returned to this year’s Australian Effie Awards
From 10 months to 10 weeks: national forum held at Parliament house looks to slash diagnosis time for juvenile arthritis in Australia
New Medicines Australia white paper calls for reforms to open more potentially life-saving cancer trials to Australian children
A new ranking reveals the lobbying firms most used by pharmaceutical companies to press their case with the Government - with one clearly ahead of the pack
A court has ruled the channels to inform the public of a class action against Johnson & Johnson can include influencers in order to reach as many people as possible
Created to navigate the increasingly complex landscape of public health priorities, Government policy, public funding and the private market
Additional biosimilar brands targeting this lucrative franchise have been approved ahead of the PBAC's meeting next month which will consider them for PBS listing
STEM students tackle the impact of climate on Australia’s $100 billion agriculture industry and the trajectory of human health
Three departures including one redundancy as leaders across industry move on, taking decades of company history with them
After a significant stretch as one of industry's longest-serving ANZ Country Leaders this former GM has landed a new role
Tens of thousands gain access to diabetes medications after Pharmac expands eligibility for funded treatments
The new radiopharma is backed by an investment syndicate led by 'Twiggy' Forrest's Tenmile with a mission to develop significant new medicines for hard-to-treat cancers
All high-strength formulations of this drug are set to be discontinued in Australia, with the TGA implementing Serious Scarcity Substitution to support ongoing patient access
Op-Ed: The return of Healthcare Marketing to Australia's prestigious Effie Awards means so much more than another gong for industry
While most specialists view MSLs positively almost a third describe their interactions as average or poor and almost one in three can't spot the difference between an MSL and Sales Rep
DBG Health has severed ties with Sam Wood, who faces two domestic violence charges, after it acquired the reality TV star’s exercise and nutrition program
Following an extended back-and-forth with the PBAC, this pharma appears to be progressing its new treatment towards a PBS listing
Slapped with the most serious Code of Conduct breach and reprimanded for a "significant failure" on transparency
Company catches up with how patients who are using this drug in the real world by kicking off a new trial and the upside could be a hike in profits
mRNA powerhouse and Australia's national science agency have launched a five-year strategic collaboration, with the first project unveiled
The new loans will be used for existing debt and corporate purposes but carry an interest rate significantly higher than the ones being replaced